Predictors of Poor Outcomes in Critically Ill Adults with Hematologic Malignancy

Marion Cornish, Michael B Butler, Robert S Green, Marion Cornish, Michael B Butler, Robert S Green

Abstract

Background. Patients with hematologic malignancy (HM) often require intensive care unit (ICU) admission due to organ failure through disease progression or treatment-related complications. Objective. To determine mortality and prognostic variables in adult patients with HM who were admitted to ICU. Methods. Structured chart review of all adult patients (age ≥ 18 years) with HM admitted to ICU of a Canadian tertiary care hospital between 2004 and 2014. Outcome measures included mortality (ICU, 30-day, 60-day, and 12-month). Logistic regression was performed to determine predictors of mortality. Results. Overall, there were 206 cases of HM admitted to the ICU during the study (mean age: 51.3 ± 13.6 years; 60% male). Median stay was 3 days, with 14.1% requiring prolonged ICU admission. ICU mortality was 45.6% and increased to 59.2% at 30 days, 62.6% at 60 days, and 74.3% at 12 months. Predictors of increased ICU mortality included mechanical ventilation requirement and vasopressor therapy requirement, while admission to ICU postoperatively and having myeloma were associated with decreased mortality. Conclusions. Patients admitted to ICU with HM have high mortality (45.6%), which increased to 74.3% at 1 year. Analysis of multiple variables identified critical illness, postsurgical admission, and myeloma as predictors of patient outcomes.

Figures

Figure 1
Figure 1
Selection of study participants.

References

    1. Brunet F., Lanore J. J., Dhainaut J. F., et al. Is intensive care justified for patients with haematological malignancies? Intensive Care Medicine. 1990;16(5):291–297. doi: 10.1007/bf01706352.
    1. Townsend W. M., Holroyd A., Pearce R., et al. Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning. British Journal of Haematology. 2013;161(4):578–586. doi: 10.1111/bjh.12294.
    1. Ñamendys-Silva S. A., González-Herrera M. O., García-Guillén F. J., Texcocano-Becerra J., Herrera-Gómez A. Outcome of critically ill patients with hematological malignancies. Annals of Hematology. 2013;92(5):699–705. doi: 10.1007/s00277-013-1675-7.
    1. Azoulay E., Pène F., Darmon M., et al. Managing critically Ill hematology patients: time to think differently. Blood Reviews. 2015;29(6):359–367. doi: 10.1016/j.blre.2015.04.002.
    1. Hill Q. A. Intensify, resuscitate or palliate: decision making in the critically ill patient with haematological malignancy. Blood Reviews. 2010;24(1):17–25. doi: 10.1016/j.blre.2009.10.002.
    1. Bird G. T., Farquhar-Smith P., Wigmore T., Potter M., Gruber P. C. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study. British Journal of Anaesthesia. 2012;108(3):452–459. doi: 10.1093/bja/aer449.
    1. Boyaci N., Aygencel G., Turkoglu M., Yegin Z. A., Acar K., Sucak G. T. The intensive care management process in patients with hematopoietic stem cell transplantation and factors affecting their prognosis. Hematology. 2014;19(6):338–345. doi: 10.1179/1607845413y.0000000130.
    1. Cherif H., Martling C.-R., Hansen J., Kalin M., Björkholm M. Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication. Supportive Care in Cancer. 2007;15(12):1393–1398. doi: 10.1007/s00520-007-0268-1.
    1. Massion P. B., Dive A. M., Doyen C., et al. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Critical Care Medicine. 2002;30(10):2260–2270. doi: 10.1097/00003246-200210000-00014.
    1. Cuthbertson B. H., Rajalingham Y., Harrison S., McKirfy F. The outcome of haematological malignancy in Scottish intensive care units. Journal of the Intensive Care Society. 2008;9:135–140.
    1. Benoit D. D., Vandewoude K. H., Decruyenaere J. M., Hoste E. A., Colardyn F. A. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Critical Care Medicine. 2003;31(1):104–112. doi: 10.1097/00003246-200301000-00017.
    1. Azoulay E., Mokart D., Pène F., et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—a groupe de recherche respiratoire en réanimation onco-hématologique study. Journal of Clinical Oncology. 2013;31(22):2810–2818. doi: 10.1200/jco.2012.47.2365.
    1. Roze des Ordons A. L., Chan K., Mirza I., Townsend D. R., Bagshaw S. M. Clinical characteristics and outcomes of patients with acute myelogenous leukemia admitted to intensive care: a case-control study. BMC Cancer. 2010;10, article 516 doi: 10.1186/1471-2407-10-516.
    1. Schellongowski P., Staudinger T., Kundi M., et al. Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica. 2011;96(2):231–237. doi: 10.3324/haematol.2010.031583.
    1. Oeyen S. G., Benoit D. D., Annemans L., et al. Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study. Intensive Care Medicine. 2013;39(5):889–898. doi: 10.1007/s00134-012-2791-x.
    1. Kew A. K., Couban S., Patrick W., Thompson K., White D. Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit. Biology of Blood and Marrow Transplantation. 2006;12(3):301–305. doi: 10.1016/j.bbmt.2005.10.020.
    1. Song J.-U., Suh G. Y., Park H. Y., et al. Early intervention on the outcomes in critically ill cancer patients admitted to intensive care units. Intensive Care Medicine. 2012;38(9):1505–1513. doi: 10.1007/s00134-012-2594-0.
    1. Geerse D. A., Span L. F. R., Pinto-Sietsma S.-J., Van Mook W. N. K. A. Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality. European Journal of Internal Medicine. 2011;22(1):57–61. doi: 10.1016/j.ejim.2010.11.003.
    1. Yeo C. D., Kim J. W., Kim S. C., et al. Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit. Journal of Critical Care. 2012;27(6):739–e6. doi: 10.1016/j.jcrc.2012.07.014.
    1. Aygencel G., Turkoglu M., Turkoz Sucak G., Benekli M. Prognostic factors in critically ill cancer patients admitted to the intensive care unit. Journal of Critical Care. 2014;29(4):618–626. doi: 10.1016/j.jcrc.2014.01.014.
    1. Turkoglu M., Erdem G. U., Suyani E., et al. Acute respiratory distress syndrome in patients with hematological malignancies. Hematology. 2013;18(3):123–130. doi: 10.1179/1607845412y.0000000038.
    1. Depuydt P., Kerre T., Noens L., et al. Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: a single-centre experience. Bone Marrow Transplantation. 2011;46(9):1186–1191. doi: 10.1038/bmt.2010.255.
    1. Faber-Langendoen K., Caplan A. L., McGlave P. B. Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone Marrow Transplantation. 1993;12(5):501–507.
    1. Scales D. C., Thiruchelvam D., Kiss A., Sibbald W. J., Redelmeier D. A. Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis. Critical Care. 2008;12(3, article R77) doi: 10.1186/cc6923.
    1. Medić M. G., Gornik I., Gašparović V. Hematologic malignancies in the medical intensive care unit—outcomes and prognostic factors. Hematology. 2015;20(5):247–253. doi: 10.1179/1607845414y.0000000206.
    1. Park M. R., Jeon K., Song J.-U., et al. Outcomes in critically ill patients with hematologic malignancies who received renal replacement therapy for acute kidney injury in an intensive care unit. Journal of Critical Care. 2011;26(1):107.e1–107.e6. doi: 10.1016/j.jcrc.2010.07.006.
    1. Huynh T. N., Weigt S. S., Belperio J. A., Territo M., Keane M. P. Outcome and prognostic indicators of patients with hematopoietic stem cell transplants admitted to the intensive care unit. Journal of Transplantation. 2009;2009:8. doi: 10.1155/2009/917294.917294
    1. Abdul-Jabbar S., Bates I., Davies G., Shulman R. An analysis of medicine costs of adult patients on a critical care unit. Journal of Critical Care. 2014;29(3):472.e7–472.e12. doi: 10.1016/j.jcrc.2013.12.014.
    1. Malak S., Sotto J.-J., Ceccaldi J., et al. Ethical and clinical aspects of intensive care unit admission in patients with hematological malignancies: guidelines of the Ethics Commission of the French Society of Hematology. Advances in Hematology. 2014;2014:8. doi: 10.1155/2014/704318.704318

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner